Awarded

SUMINISTRO DE MEDICAMENTOS EXCLUSIVOS: ERENUMAB (AIMOVIG), BACLOFENO (LIORESAL INTRATECAL), OCTEOTRIDO IM (SANDOSTATIN LAR), EVEROLIMUS INMUNOSUPRESOR (CERTICAN), RIBOCICLIB (KISQALI) Y LAPATINIB (TYVERB)

Track this recordFree account — get alerted when a contract here runs out.
Contract value
€91,268
Bids received
1
Published
8 Jul 2026
Awarded
20 Apr 2026
Contract start
20 Apr 2026
Contract end
21 Apr 2027estimated
Region
Madrid

More awards from this buyer